ArticleJournal of cellular and molecular medicine2017

Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.

Jing-Dong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.